Virtu Financial’s Freeline Therapeutics Holdings plc American Depositary Shares FRLN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-1,111
Closed -$8K 2265
2023
Q1
$8K Buy
+1,111
New +$8.62K ﹤0.01% 1369

Other funds holding FRLN

Virtu Financial's FRLN Position: Q2 2023 in Review

Virtu Financial sold out of Freeline Therapeutics Holdings plc American Depositary Shares (FRLN) in Q2 2023, closing a stake of 1,111 shares — an estimated $8K sold.

Virtu Financial first reported a position in FRLN in Q1 2023 and held it in 1 quarter. The position peaked at $8K in Q1 2023. 11 funds tracked by Wall St. Rank hold FRLN as of Q2 2023.

  • Virtu Financial reported no remaining Freeline Therapeutics Holdings plc American Depositary Shares position as of Q2 2023 after selling out during the quarter.
  • Virtu Financial sold 1,111 Freeline Therapeutics Holdings plc American Depositary Shares shares in Q2 2023, an estimated $8K.
  • Virtu Financial first reported a position in Freeline Therapeutics Holdings plc American Depositary Shares in Q1 2023 and held it in 1 quarter.
  • Virtu Financial's Freeline Therapeutics Holdings plc American Depositary Shares position peaked at $8K in Q1 2023.
  • 11 funds tracked by Wall St. Rank held Freeline Therapeutics Holdings plc American Depositary Shares as of Q2 2023.

Based on Virtu Financial's 13F filing for Q2 2023, filed 27 Jul 2023.